checkAd
    Startseite > Aktien > Arcutis Biotherapeutics > Nachrichten
    Arcutis Biotherapeutics Aktie
    8,7800
     
    USD
    +3,66 %
    +0,3100 USD
    Letzter Kurs 02:00:00 Nasdaq
    8,7900
     
    USD
    800 STK
    Geldkurs 29.04.24
    8,8100
     
    USD
    15.700 STK
    Briefkurs 29.04.24
    ISIN: US03969K1088 · WKN: A2PYWE · SYM: ARQT · USA

    Neueste Nachrichten

    Arcutis to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
    29.04.24 · globenewswire · Arcutis Biotherapeutics
    Arcutis Appoints David Topper as Chief Financial Officer
    10.04.24 · globenewswire · Arcutis Biotherapeutics
    Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    05.04.24 · globenewswire · Arcutis Biotherapeutics
    Arcutis to Present at the 23rd Annual Needham Virtual Healthcare Conference
    28.03.24 · globenewswire · Arcutis Biotherapeutics
    Arcutis Promotes Todd Tucker to Chief Human Resources Officer
    11.03.24 · globenewswire · Arcutis Biotherapeutics
    Arcutis Presents Late-Breaking Data From INTEGUMENT-PED Phase 3 Trial of Roflumilast Cream 0.05% in Atopic Dermatitis in Children Ages 2 to 5 at the American Academy of Dermatology Annual Meeting
    10.03.24 · globenewswire · Arcutis Biotherapeutics
    New Research Reveals Genomic Profile of Seborrheic Dermatitis and Answers Key Questions on Immune Response and Skin Barrier Dysfunction
    09.03.24 · globenewswire · Arcutis Biotherapeutics
    Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    05.03.24 · globenewswire · Arcutis Biotherapeutics
    Arcutis Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
    04.03.24 · globenewswire · Arcutis Biotherapeutics
    Arcutis Announces Acceptance of Late Breaking Abstract in Atopic Dermatitis Among Five New Topical Roflumilast Data Being Presented at the American Academy of Dermatology Annual Meeting
    04.03.24 · globenewswire · Arcutis Biotherapeutics
    Arcutis to Present at the TD Cowen 44th Annual Health Care Conference
    29.02.24 · globenewswire · Arcutis Biotherapeutics
    Arcutis Announces Pricing of $150 Million Public Offering
    29.02.24 · globenewswire · Arcutis Biotherapeutics